Lieser Brian 4
4 · BELDEN INC. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
BELDEN INC.BDC
Lieser Brian
EVP - Chief Comm. Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-04$53.79/sh+2,516$135,336→ 31,590 total - Disposition to Issuer
Common Stock
2025-12-04$120.69/sh−1,759$212,303→ 29,831 total - Exercise/Conversion
Common Stock
2025-12-04$74.91/sh+1,210$90,641→ 31,041 total - Disposition to Issuer
Common Stock
2025-12-04$120.69/sh−961$115,988→ 30,080 total - Exercise/Conversion
Common Stock
2025-12-04$72.73/sh+1,225$89,094→ 31,305 total - Sale
Common Stock
2025-12-05$120.00/sh−1,270$152,400→ 29,074 total - Exercise/Conversion
Stock Appreciation Rights
2025-12-04−1,210→ 0 totalExercise: $74.91Exp: 2027-02-22→ Common Stock (1,210 underlying) - Exercise/Conversion
Stock Appreciation Rights
2025-12-04−1,225→ 0 totalExercise: $72.73Exp: 2028-02-28→ Common Stock (1,225 underlying) - Exercise/Conversion
Stock Appreciation Rights
2025-12-04−2,516→ 0 totalExercise: $53.79Exp: 2032-02-22→ Common Stock (2,516 underlying)
Holdings
- 505.145(indirect: By 401(k))
Common Stock
Footnotes (7)
- [F1]The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
- [F2]Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
- [F3]This represents the difference between the number of SARs exercised (2,516) and the number of shares issued as a result of the exercise (757). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
- [F4]This represents the difference between the number of SARs exercised (1,210) and the number of shares issued as a result of the exercise (249). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($74.91). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
- [F5]This represents the difference between the number of SARs exercised (1,225) and the number of shares issued as a result of the exercise (264). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($120.695) and the exercise price ($72.73). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
- [F6]The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Lieser on August 11, 2025.
- [F7]The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.